B. Biersack et al. / Bioorg. Med. Chem. Lett. 21 (2011) 6270–6273
6273
6. Beauregard, D. A.; Thelwall, P. E.; Chaplin, D. J.; Hill, S. A.; Adams, G. E.; Brindle,
K. M. Br. J. Cancer 1998, 77, 1761.
7. Bilenker, J. H.; Flaherty, K. T.; Rosen, M.; Davis, L.; Gallagher, M.; Stevenson, J.
P.; Sun, W.; Vaughn, D.; Giantonio, B.; Zimmer, R.; Schnall, M.; O’Dowyer, P. J.
Clin. Cancer Res. 2005, 11, 1527.
8. Garon, E.; Kabbinavar, F.; Balkisson, J.; Lu, S. P.; Neidhart, J.; Neidhart, J.;
Gabrail, N.; Ribeiro de Oliveria, M. AACR-EORTC-NCI Molecular Targets and
Cancer Therapeutics Conference, Boston, MA, November 15–18, 2009.
9. Kirwan, I. G.; Loadman, P. M.; Swaine, D. J.; Anthoney, D. A.; Pettit, G. R., et al
Clin. Cancer Res. 2004, 10, 1446.
of the growth of KB-3-1 cervix and PC-3 prostate cancer cells. For
growth inhibition of the L929 mouse fibroblasts a residue larger
than bromine, for example, iodine (6h) or methoxy (6c), has to
be present in one of the meta-positions of the B-ring. It will be
interesting to see whether the new imidazoles are as well tolerated
in mice as the previously reported analogs 3.
Acknowledgment
10. Aprile, S.; Del Grosso, E.; Tron, G. C.; Grosa, G. Drug Metab. Dispos. 2007, 35,
2252.
This work was funded by the Deutsche ForschungsGemeinschaft
DFG (Grant Scho 402/8-3).
11. Gaukroger, K.; Hadfield, J. A.; Lawrence, N. J.; Nolan, S.; McGown, A. T. Org.
Biomol. Chem. 2003, 1, 3033.
12. Pettit, G. R.; Minardi, M. D.; Rosenberg, H. J.; Hamel, E.; Bibby, M. C.; Martin, S.
W.; Jung, M. K.; Pettit, R. K.; Cuthbertson, T. J.; Chapuis, J.-C. J. Nat. Prod. 2005,
68, 1450.
13. Hall, J. J.; Sriram, M.; Strecker, T. E.; Tidmore, J. K.; Jelinek, C. J.; Kumar, G. D. K.;
Hadimani, M. B.; Pettit, G. R.; Chaplin, D. J.; Trawick, M. L.; Pinney, K. G. Bioorg.
Med. Chem. Lett. 2008, 18, 5146.
14. Lawrence, N. J.; Hepworth, L. A.; Rennison, D.; McGown, A. T.; Hadfield, J. A. J.
Fluorine Chem. 2003, 123, 101.
Supplementary data
Supplementary data associated (details of the synthesis, charac-
terization, and purity of compounds 6 and of the biological assays
(MTT, HUVEC tube formation, tubulin polymerization, immunoflu-
orescence staining of PtK2 cells)) with this article can be found, in
15. Beale, T. M.; Myers, R. M.; Shearman, J. W.; Charnock-Jones, D. S.; Brenton, J. D.;
Gergely, F. V.; Ley, S. V. Med. Chem. Commun. 2010, 1, 202.
16. Karjala, G.; Chan, Q.; Manzo, E.; Andersen, R. J.; Roberge, M. Cancer Res. 2005,
65, 3040.
17. Wang, L.; Woods, K. W.; Li, Q.; Barr, K. J.; McCroskey, R. W.; Hannick, S. M.;
Gherke, L.; Credo, R. B.; Hui, Y.-H.; Marsh, K.; Warner, R.; Lee, J. Y.; Zielinski-
Mozng, N.; Frost, D.; Rosenberg, S. H.; Sham, H. L. J. Med. Chem. 2002, 45, 1697.
18. (a) Bellina, F.; Cauteruccio, S.; Di Fiore, A.; Rossi, R. Eur. J. Org. Chem. 2008,
5436; (b) Bonezzi, K.; Taraboletti, G.; Borsotti, P.; Bellina, F.; Rossi, R.; Giavazzi,
R. J. Med. Chem. 2009, 52, 7906.
19. Schobert, R.; Biersack, B.; Dietrich, A.; Effenberger, K.; Knauer, S.; Mueller, T. J.
Med. Chem. 2010, 53, 6595.
20. Clark, M. T.; Miller, D. D. J. Org. Chem. 1986, 51, 4072.
21. Gaskin, F.; Cantor, C. R.; Schelanski, M. J. Mol. Biol. 1974, 98, 737.
References and notes
1. Pettit, G. R.; Singh, S. B.; Hamel, E.; Lin, C. M.; Alberts, D. S.; Garcia-Kendall, D.
Experientia 1989, 45, 209.
2. Mooney, C. J.; Nagaiah, G.; Fu, P.; Wasman, J. K.; Cooney, M. M.; Savvides, P. S.;
Bokar, J. A.; Dowlati, A.; Wang, D.; Agarwala, S. S.; Flick, S. M.; Hartman, P. H.;
Ortiz, J. D.; Lavertu, P. N.; Remick, S. C. Thyroid 2009, 19, 233.
3. Delmonte, A.; Sessa, C. Expert. Opin. Invest. Drugs 2009, 18, 1541.
4. Lippert, J. W. Bioorg. Med. Chem. 2007, 15, 605.
5. Kanthou, K.; Tozer, G. M. Blood 2002, 99, 2060.